…would say yes, but that was not of interest to him. Really? You know, he did not have, for instance, when you talk to Schultes, or when I would speak to Schultes now and then, even though Schultes was a button-down type of New Englander with, you know,…

…interest to him. Really? You know, he did not have, for instance, when you talk to Schultes, or when I would speak to Schultes now and then, even though Schultes was a button-down type of New Englander with, you know, he wore a vest in 90-degree…

…he did not have, for instance, when you talk to Schultes, or when I would speak to Schultes now and then, even though Schultes was a button-down type of New Englander with, you know, he wore a vest in 90-degree weather, you know, under his jacket, there…

…you know, letters after my name. I'm just an amateur. An amateur in the best sense of the word, the same way that Schultes tagged Wasson with the mushrooms, said, look, he was an amateur. He didn't study courses, but he studied more than people who knew…

…starting this afternoon, I'll go through. I've got a box, a small box, but it's letters from the people in the museum with Schultes, you know, with Wasson and McKenna. It's just they're kind of important to me. Of course. I managed to get these guys to…

…important to me. Of course. I managed to get these guys to give me a phone call, to write me a note. The first time I wrote Schultes to be able to get a, I needed an in, okay? And because I admired the guy for 30 years, but I had no in. Why…

…not going to work. So Wasson had died and he had died, it was coming up in a year. And I said, you know, Dr. Schultes, I would really love, years past since your good friend died, I would love to talk about your relationship and how you managed to…

…was pretty early on. That was their sacrament. Then that was, by analog law, made illegal by the feds. And so they talked to Schultes and said, you know, the medicine you make us, you won't make us anymore. He said, well, I can't. You know, it's now…

…called DPT, which is maybe one little molecule off the DMT. And it was, you know, it was really a thumb in the nose by Schultes, by Shulgin, to, you know, to the U.S. government, you know. And so I ended up doing the DP team because the other one…

…bioactivity or any particular activity in it that might be of interest. So it's totally hit or miss. Shama Pharmaceutical, which had Richard Schultes at its head, decided to try something else. They said no. We can't, we don't have the money to spend, you…